BACKGROUND: Although obsessive-compulsive disorder (OCD) is typically described as a chronic condition, relatively little is known about the naturalistic, longitudinal course of the disorder. The purpose of the current study was to examine the probability of OCD remission and recurrence as well as to explore demographic and clinical predictors of remission. METHODS: This study uses data from the Harvard/Brown Anxiety Disorders Research Program, which is a prospective, naturalistic, longitudinal study of anxiety disorders. Diagnoses were established by means of a clinical interview at study intake. One hundred thirteen Harvard/Brown Anxiety Disorders Research Program participants with OCD were included in the study; all had a history of at least 1 other anxiety disorder. Assessments were conducted at 6-month and/or annual intervals during 15 years of follow-up. RESULTS: Survival analyses showed that the probability of OCD remission was .16 at year 1, .25 at year 5, .31 at year 10, and .42 at year 15. For those who remitted from OCD, the probability of recurrence was .07 at year 1, .15 by year 3, and by year 5, it reached .25 and remained at .25 through year 15. In predictors of course, those who were married and those without comorbid major depressive disorder (MDD) were more likely to remit from OCD. By year 15, 51% of those without MDD remitted from OCD compared to only 20% of those with MDD. CONCLUSIONS: In the short term, OCD appears to have a chronic course with low rates of remission. However, in the long term, a fair number of people recover from the disorder, and, for those who experience remission from OCD, the probability of recurrence is fairly low.
BACKGROUND: Although obsessive-compulsive disorder (OCD) is typically described as a chronic condition, relatively little is known about the naturalistic, longitudinal course of the disorder. The purpose of the current study was to examine the probability of OCD remission and recurrence as well as to explore demographic and clinical predictors of remission. METHODS: This study uses data from the Harvard/Brown Anxiety Disorders Research Program, which is a prospective, naturalistic, longitudinal study of anxiety disorders. Diagnoses were established by means of a clinical interview at study intake. One hundred thirteen Harvard/Brown Anxiety Disorders Research Program participants with OCD were included in the study; all had a history of at least 1 other anxiety disorder. Assessments were conducted at 6-month and/or annual intervals during 15 years of follow-up. RESULTS: Survival analyses showed that the probability of OCD remission was .16 at year 1, .25 at year 5, .31 at year 10, and .42 at year 15. For those who remitted from OCD, the probability of recurrence was .07 at year 1, .15 by year 3, and by year 5, it reached .25 and remained at .25 through year 15. In predictors of course, those who were married and those without comorbid major depressive disorder (MDD) were more likely to remit from OCD. By year 15, 51% of those without MDD remitted from OCD compared to only 20% of those with MDD. CONCLUSIONS: In the short term, OCD appears to have a chronic course with low rates of remission. However, in the long term, a fair number of people recover from the disorder, and, for those who experience remission from OCD, the probability of recurrence is fairly low.
Authors: I M Goldenberg; K White; K Yonkers; J Reich; M G Warshaw; R M Goisman; M B Keller Journal: J Clin Psychiatry Date: 1996-11 Impact factor: 4.384
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Albina R Torres; Martin J Prince; Paul E Bebbington; Dinesh Bhugra; Traolach S Brugha; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Nicola Singleton Journal: Am J Psychiatry Date: 2006-11 Impact factor: 18.112
Authors: Juliana B Diniz; Maria C Rosario-Campos; Roseli G Shavitt; Mariana Curi; Ana G Hounie; Sergio A Brotto; Euripedes C Miguel Journal: J Clin Psychiatry Date: 2004-01 Impact factor: 4.384
Authors: W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney Journal: Arch Gen Psychiatry Date: 1989-11
Authors: Sarah L Garnaat; Christina L Boisseau; Agustin Yip; Nicholas J Sibrava; Benjamin D Greenberg; Maria C Mancebo; Nicole C R McLaughlin; Jane L Eisen; Steven A Rasmussen Journal: J Clin Psychiatry Date: 2015-12 Impact factor: 4.384
Authors: Maria C Mancebo; Christina L Boisseau; Sarah L Garnaat; Jane L Eisen; Benjamin D Greenberg; Nicholas J Sibrava; Robert L Stout; Steven A Rasmussen Journal: Compr Psychiatry Date: 2014-04-24 Impact factor: 3.735
Authors: Kathleen D Askland; Sarah Garnaat; Nicholas J Sibrava; Christina L Boisseau; David Strong; Maria Mancebo; Benjamin Greenberg; Steve Rasmussen; Jane Eisen Journal: Int J Methods Psychiatr Res Date: 2015-05-21 Impact factor: 4.035
Authors: Brian L Odlaug; Eric Weinhandl; Maria C Mancebo; Erik L Mortensen; Jane L Eisen; Steven A Rasmussen; Liana R N Schreiber; Jon E Grant Journal: Ann Clin Psychiatry Date: 2014-02 Impact factor: 1.567
Authors: Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen Journal: Int J Methods Psychiatr Res Date: 2012-08-01 Impact factor: 4.035